Xarelto Lawsuit | Side Effects: Serious Internal Bleeding

Xarelto Lawsuit | Xarelto Serious Bleeding Lawsuit

Xarelto Lawsuit, Xarelto Serious Bleeding Lawsuit | Side Effects: Gastrointestinal Bleeding, Brain Bleeds, Blood Clots, Heart Attack, Stroke, Severe Hemorrhages, Severe Internal Bleeding, Death | Blood Thinner Lawsuits, Internal Bleeding Lawsuits | Xarelto Lawsuit | Xarelto Side Effects Lawsuit

Xarelto-Lawsuit-AttorneyXarelto Lawsuit Information: Xarelto, a new-generation blood thinner that has become a blockbuster seller for its manufacturers, is the subject of a growing number of lawsuits that accuse Johnson & Johnson and Bayer Healthcare of failing to warn patients of its association with uncontrollable internal bleeding and related complications. Xarelto lawsuit plaintiffs also claim that the companies misled patients by positioning the drug as a superior alternative to an older blood thinner called warfarin. Among other things, they point out that administering a low dose of vitamin K can be used to stop the internal hemorrhaging that often accompanies the use of warfarin. There is currently no approved antidote to reverse Xarelto bleeding.

Xarelto Lawsuits due to serious bleeding side effects

By 2014, Xarelto lawsuits were beginning to mount in U.S. courts, all which were filed on behalf of patients who allegedly experienced dangerous, uncontrollable bleeding due to the medication. Among other things, plaintiffs in these cases allege that the drugs’ manufacturers failed to adequately warn consumers and the medical community about the potential bleeding risks associated with Xarelto, as well as the lack of an effective reversal agent. Plaintiffs also dispute the drug companies’ assertions that Xarelto patients don’t require regular blood monitoring, and point to studies that suggest such testing could be beneficial for people using the medication.
(Xarelto Lawsuit Case No. In Re: Xarelto Products Liability Litigation, No. 2592)

In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits in a multidistrict litigation, and transferred pending cases to the U.S. District Court, Eastern District of Louisiana. All future Xarelto claims will also be transferred to that proceeding, where the docket will undergo coordinated pretrial proceedings. Multidistrict litigations are established when it is anticipated that a large number of product liability claims involving similar injuries will be filed over a single product, or a group of similar products. Such proceedings are intended to conserve the resources of the Court, parties and witnesses, and to avoid duplicative discovery and inconsistent rulings across a large number of similar lawsuits.

You may be entitled to compensation if you or a loved one suffered life-threatening complications related to the use of Xarelto, including:

  • Internal bleeding
  • Cerebral bleeding
  • Gastrointestinal hemorrhaging
  • Stroke
  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)
  • Death

As both an attorney and practicing physician, Dr. François Blaudeau possesses a unique understanding of the medical and legal questions at issue in Xarelto lawsuits. To learn more about your legal rights, please call Dr. Blaudeau as soon as possible for a free, no-obligation case review.

Xarelto Bleeding Complication Side Effects

Xarelto, known generically as rivaroxaban, was approved by the U.S. Food & Drug Administration (FDA) in 2011. The drug is manufactured by Germany-based Bayer Healthcare, but marketing of the medication in the U.S. is handled by Johnson & Johnson’s Janssen Pharmaceutica division. Xarelto was initially approved to reduce risk of strokes, DVT, PE, and blood clots in patients who have undergone hip or knee replacement surgery. Its approved indications have since been expanded to include the prevention of blood clots in people with atrial fibrillation, as well as the treatment of DVT and PE.

By 2013, Xarelto sales had exceeded $2 billion. In the third quarter of 2014, sales of the blood thinner had generated $414 million for Johnson & Johnson and another $522.5 million for Bayer. According to Xarelto lawsuits, sales of the medication were driven by the companies’ claims that it was easier to use than warfarin, which requires frequent blood monitoring.

Despite promises of Xarelto’s superiority over warfarin, adverse events involving the blood thinner began to mount soon after its approval. For example, a German newspaper recently revealed that during the first eight months of 2013, 968 Xarelto complications had been reported to officials in that country, including 72 deaths.

In 2014, the Institute for Safe Medicine Practices reported that adverse events related to the use of Xarelto had surpassed those involving Pradaxa, a blood thinner in the same class. According to the group, the FDA tallied 680 serious adverse event reports associated with Xarelto over the previous year, compared to only 528 for Pradaxa

Legal Help for Victims of Xarelto Bleeding Complications

Throughout his career, Dr. Blaudeau has worked hard to develop a strong reputation in healthcare litigation. His first-hand knowledge of medicine has made Southern Med Law an aggressive and effective advocate for those who were harmed due to dangerous and defective drugs. If you or a loved one experienced life-threatening Xarelto bleeding complications, please contact the Firm today to learn more about your legal rights. You can arrange for a free, no obligation Xarelto lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.